PubRank

John F Bresnahan

Author PubWeight™ 20.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation 2007 2.47
2 Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J 2013 1.76
3 Ambulation 1 hour after diagnostic cardiac catheterization: a prospective study of 1009 procedures. Mayo Clin Proc 2006 1.67
4 Transcatheter aortic valve insertion catastrophe in inoperable patients: should aortic valve replacement be denied? J Card Surg 2013 1.39
5 Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention. Mayo Clin Proc 2008 1.38
6 Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 2006 1.31
7 "Broken heart syndrome" after separation (from OxyContin). Mayo Clin Proc 2006 1.19
8 Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort. Catheter Cardiovasc Interv 2008 1.07
9 Drug-eluting stents in octogenarians: early and intermediate outcome. Am Heart J 2008 0.88
10 Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol 2002 0.84
11 Endovascular abdominal aortic aneurysm repair to facilitate access for transcatheter aortic valve implantation. Ann Thorac Surg 2013 0.81
12 Comparison of drug-eluting and bare-metal stents for stable coronary artery disease. JACC Cardiovasc Interv 2009 0.80
13 Chronic traumatic aneurysm of the left main coronary artery causing myocardial infarction. Ann Thorac Surg 2005 0.79
14 Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Catheter Cardiovasc Interv 2004 0.79
15 High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice. Circ Cardiovasc Interv 2012 0.78
16 Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization. Catheter Cardiovasc Interv 2007 0.78
17 Sex-related differences in fractional flow reserve-guided treatment. Circ Cardiovasc Interv 2013 0.77
18 Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv 2012 0.76
19 Clinical and economic outcomes after introduction of drug-eluting stents. Am J Manag Care 2010 0.75
20 Angiographically silent very late stent thrombosis detected by optical coherence tomography in association with peri-stent staining and multiple interstrut cavities. Eur Heart J Cardiovasc Imaging 2012 0.75
21 Filter neuroprotection of a single patent internal carotid artery during transapical aortic valve implantation. J Card Surg 2014 0.75
22 Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trial. J Interv Cardiol 2010 0.75